Back

Hypokalemia during hospitalization: a strong predictor of mortality in acute heart failure

19 May 2025 (09:00 - 09:45)
Organised by: Logo
Congress Presentation Part of: Heart failure management and prognosis across disease stages and patient populations Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Mr Pedro Castello Branco De Moraes

State University of Rio de Janeiro (UERJ), Rio de Janeiro (Brazil)

5 More presentations in this session

Presentation thumbnail
Adults with fontan circulation: insights from a Portuguese adult congenital heart disease center
Doctor A. Pinho (Porto, PT)
Abstract Slides Video
Presentation thumbnail
Comparative mortality in hfref on guideline-directed medical therapy versus malignant cancer: insights from a global federated research dataset
Doctor L. Monzo (Vandoeuvre-Les-Nancy, FR)
Abstract Slides Video
Presentation thumbnail
Comorbidities in heart failure: data from the hungarian nationwide epidemiological study (HF-EPI-HUN) over a 15-year period (2009-2023)
Associate Professor T. Habon (Pecs, HU)
Abstract Slides Video
Presentation thumbnail
Machine learning-derived phenotypes in heart failure with reduced ejection fraction: clinical implications beyond LVEF
Mr D. Ferreira (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
The impact of the high doses of loop diuretics on nutritional status in patients with heart failure with reduced ejection fraction
Miss A. Soloch (Poznan, PL)
Abstract Slides Video

Access the full session

Session thumbnail
Heart failure management and prognosis across disease stages and patient populations

The Event

Event poster

Heart Failure 2025

19 May 2025 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic value of hyperkalemia and mineralocorticoid receptor antagonist use in heart failure: a national registry study
thumbnail
Congress Presentation
Incorporating hypochloremia provides additive prognostic information in hospitalized patients with heart failure
thumbnail
Congress Presentation
Hyperkalemia events in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan or sodium-glucose transport protein 2 inhibitors: a single-center experience

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources